Jennifer Roost, MD
Gastroenterology · Menlo Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Roost’s office at (650) 498-6500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A75552 · Current
Licensed to practise in California · since 2001 · expires 2027-04-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$47,342
Medicare paid this office $47,342 for 210 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 42 | $9,740 | $232 |
| Biopsy of large bowel using a flexible endoscope | 76 | $9,072 | $119 |
| New patient visit (45+ min) | 40 | $5,918 | $148 |
| New patient visit (30+ min) | 40 | $3,966 | $99 |
| Long return visit (40+ min) | 20 | $3,491 | $159 |
See all 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 42 | $9,740 | $232 |
| Biopsy of large bowel using a flexible endoscope | 76 | $9,072 | $119 |
| New patient visit (45+ min) | 40 | $5,918 | $148 |
| New patient visit (30+ min) | 40 | $3,966 | $99 |
| Long return visit (40+ min) | 20 | $3,491 | $159 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,881 | $206 |
| Return visit (30+ min) | 23 | $2,762 | $110 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | $1,917 | $91 |
| Short return visit (20+ min) | 19 | $1,757 | $80 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 92 | $1,488 | $14 |
Procedures Medicare counted
| Colonoscopy | 51 | More than 64% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 11 | More than 42% of doctors who do this |
Who their Medicare patients are
210 Original Medicare patients in 2024. Average age 73 · Women 71% · Also on Medicaid 9% · Health risk score 0.86. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 51% · Coronary heart disease 19% · Diabetes 18% · Depression 17% · Cancer 16% · Atrial fibrillation 13% · Chronic kidney disease 11% · COPD 8% · Heart failure 6%.
The office billed $442,814, Medicare allowed $59,260 and paid $47,342; for 441 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 210 | 441 | 73 | 0.86 | $442,814 | $47,342 |
| 2023 | 266 | 541 | 75 | 0.77 | $557,355 | $56,909 |
| 2022 | 326 | 701 | 74 | 0.69 | $608,977 | $70,085 |
| 2021 | 340 | 765 | 75 | 0.76 | $709,884 | $78,665 |
| 2020 | 309 | 622 | 74 | 0.84 | $561,906 | $60,790 |
| 2019 | 377 | 780 | 74 | 0.77 | $731,990 | $78,832 |
| 2018 | 356 | 935 | 73 | 0.82 | $711,001 | $78,361 |
| 2017 | 367 | 1,043 | 73 | 0.93 | $747,687 | $86,882 |
| 2016 | 334 | 512 | 73 | 0.93 | $515,426 | $66,960 |
| 2015 | 346 | 559 | 73 | 0.80 | $615,662 | $92,955 |
| 2014 | 264 | 390 | 73 | 0.94 | $415,955 | $57,300 |
| 2013 | 257 | 410 | 73 | 1.13 | $415,208 | $57,183 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Biopsy of large bowel using a flexible endoscope | 110 | $13,856 | $126 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 52 | $12,699 | $244 |
| Long return visit (40+ min) | 24 | $4,163 | $160 |
| Return visit (30+ min) | 33 | $3,904 | $108 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 38 | $3,470 | $91 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,742 | $211 |
| Short return visit (20+ min) | 35 | $2,669 | $76 |
| New patient visit (30+ min) | 15 | $1,309 | $87 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 141 | $680 | $5 |
2022: 12 services
| Biopsy of large bowel using a flexible endoscope | 125 | $16,958 | $135 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 44 | $10,325 | $235 |
| Long return visit (40+ min) | 37 | $7,615 | $169 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 28 | $5,942 | $212 |
| Return visit (30+ min) | 46 | $5,815 | $114 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | $4,015 | $82 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | $2,771 | $213 |
| New patient visit (30+ min) | 29 | $2,605 | $90 |
| Short return visit (20+ min) | 28 | $2,397 | $83 |
| New patient visit (45+ min) | 15 | $2,326 | $155 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 191 | $960 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $829 | $22 |
2021: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 77 | $18,496 | $237 |
| Biopsy of large bowel using a flexible endoscope | 151 | $17,746 | $117 |
| Long return visit (40+ min) | 35 | $7,461 | $166 |
| Return visit (30+ min) | 57 | $6,642 | $105 |
| New patient visit (45+ min) | 29 | $4,325 | $149 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 20 | $4,320 | $216 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $4,083 | $85 |
| Short return visit (20+ min) | 30 | $3,004 | $83 |
| New patient visit (30+ min) | 20 | $2,094 | $105 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 195 | $991 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $323 | $18 |
2020: 9 services
| Biopsy of large bowel using a flexible endoscope | 129 | $17,790 | $138 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 44 | $10,641 | $242 |
| Short return visit (20+ min) | 61 | $4,534 | $64 |
| Return visit (30+ min) | 45 | $4,512 | $96 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 47 | $3,945 | $84 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,727 | $219 |
| New patient visit (30+ min) | 27 | $2,448 | $91 |
| New patient visit (45+ min) | 13 | $2,068 | $159 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 169 | $871 | $5 |
2019: 11 services
| Biopsy of large bowel using a flexible endoscope | 159 | $18,834 | $118 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 74 | $17,341 | $234 |
| Return visit (30+ min) | 75 | $7,650 | $91 |
| Short return visit (20+ min) | 51 | $3,760 | $63 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,666 | $216 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,397 | $97 |
| New patient visit (45+ min) | 17 | $2,475 | $146 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,374 | $216 |
| New patient visit (30+ min) | 28 | $2,370 | $85 |
| Long return visit (40+ min) | 15 | $1,948 | $130 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 215 | $1,081 | $5 |
2018: 13 services
| Biopsy of large bowel using a flexible endoscope | 152 | $17,764 | $117 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 68 | $15,784 | $232 |
| Return visit (30+ min) | 73 | $7,837 | $94 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 19 | $4,036 | $212 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $3,387 | $83 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,869 | $205 |
| New patient visit (45+ min) | 22 | $2,837 | $129 |
| Long return visit (40+ min) | 18 | $2,456 | $136 |
| Short return visit (20+ min) | 40 | $2,413 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 120 | $1,756 | $11 |
| New patient visit (30+ min) | 20 | $1,626 | $81 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 219 | $1,063 | $5 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $967 | $81 |
2017: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 69 | $16,536 | $233 |
| Biopsy of large bowel using a flexible endoscope | 139 | $15,825 | $111 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $10,585 | $882 |
| Return visit (30+ min) | 76 | $9,335 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $4,696 | $94 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,454 | $212 |
| New patient visit (45+ min) | 21 | $3,192 | $152 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,973 | $212 |
| New patient visit (30+ min) | 33 | $2,620 | $79 |
| Short return visit (20+ min) | 34 | $2,353 | $64 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 153 | $2,216 | $11 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,215 | $81 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $957 | $74 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 181 | $826 | $4 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $629 | $35 |
| Injection beneath lining of large bowel using a flexible endoscope | 12 | $353 | $29 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $327 | $11 |
2016: 10 services
| Biopsy of large bowel using a flexible endoscope | 103 | $13,441 | $129 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 54 | $12,653 | $234 |
| Return visit (30+ min) | 86 | $8,854 | $92 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,468 | $99 |
| New patient visit (45+ min) | 23 | $3,196 | $139 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,608 | $217 |
| New patient visit (30+ min) | 29 | $2,409 | $83 |
| Long return visit (40+ min) | 14 | $2,289 | $135 |
| Short return visit (20+ min) | 30 | $1,983 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,309 | $87 |
2015: 14 services
| Biopsy of large bowel using a flexible endoscope | 133 | $23,470 | $176 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 51 | $14,251 | $279 |
| Imaging of digestive tract done from the inside of the digestive tract | 11 | $10,684 | $971 |
| Return visit (30+ min) | 76 | $7,922 | $99 |
| New patient visit (45+ min) | 33 | $4,979 | $151 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 20 | $4,818 | $241 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $4,369 | $243 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $4,005 | $98 |
| New patient visit (30+ min) | 29 | $2,967 | $102 |
| Long return visit (40+ min) | 14 | $2,270 | $142 |
| Short return visit (20+ min) | 21 | $1,876 | $69 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,223 | $94 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,134 | $94 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $511 | $34 |
2014: 10 services
| Biopsy of large bowel using a flexible endoscope | 102 | $17,677 | $173 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 33 | $8,926 | $270 |
| Return visit (30+ min) | 35 | $3,664 | $94 |
| Short return visit (20+ min) | 48 | $3,603 | $61 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $3,131 | $241 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,890 | $241 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,108 | $81 |
| New patient visit (45+ min) | 12 | $1,706 | $142 |
| New patient visit (30+ min) | 17 | $1,587 | $93 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,257 | $97 |
2013: 11 services
| Biopsy of large bowel using a flexible endoscope | 74 | $12,550 | $170 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 33 | $8,800 | $267 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $3,565 | $105 |
| Return visit (30+ min) | 32 | $3,386 | $94 |
| Short return visit (20+ min) | 46 | $3,322 | $58 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,894 | $241 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,653 | $241 |
| New patient visit (30+ min) | 29 | $2,595 | $89 |
| New patient visit (45+ min) | 12 | $1,815 | $151 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,584 | $113 |
| Short return visit | 18 | $773 | $39 |
Drugs they prescribed that Part D paid
$70,041
Pharmacies billed $70,041 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 259) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
191 generic and 68 brand-name prescriptions · $70,041 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Sod Sulf-Potass Sulf-Mag Sulf | 80 | $5,064 | $63 |
| Budesonide Dr | 11 | $1,125 | $102 |
| Diphenoxylate-Atropine | 13 | $1,036 | $80 |
| Omeprazole | 30 | $466 | $16 |
Year by year
| 2024 | 259 | 143 | 0% (0) | 26% | $70,041 |
| 2023 | 422 | 204 | 0% (0) | 30% | $86,380 |
| 2022 | 426 | 200 | None | 39% | $148,135 |
| 2021 | 518 | 270 | None | 46% | $101,326 |
| 2020 | 530 | 233 | None | 38% | $107,115 |
| 2019 | 582 | 291 | None | 46% | $101,856 |
| 2018 | 449 | 231 | None | 32% | $69,555 |
| 2017 | 518 | 237 | 0% (0) | 37% | $291,909 |
| 2016 | 458 | 209 | 0% (0) | 43% | $93,794 |
| 2015 | 504 | 222 | None | 45% | $148,076 |
| 2014 | 369 | 173 | 0% (0) | None | $50,845 |
| 2013 | 396 | 162 | None | None | $66,211 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Sod Sulf-Potass Sulf-Mag Sulf | 99 | $7,782 | $79 |
| Creon | 11 | $7,233 | $658 |
| Pantoprazole | 35 | $1,083 | $31 |
| Azathioprine | 16 | $1,067 | $67 |
| Omeprazole | 51 | $786 | $15 |
| Diphenoxylate-Atropine | 12 | $705 | $59 |
| Esomeprazole Magnesium | 11 | $413 | $38 |
| Peg 3350-Electrolyte | 18 | $362 | $20 |
| Famotidine | 15 | $249 | $17 |
2022: 11 drugs
| Creon | 17 | $74,005 | $4,353 |
| Dexilant | 13 | $12,404 | $954 |
| Linzess | 12 | $11,482 | $957 |
| Suprep | 85 | $9,797 | $115 |
| Budesonide Dr | 18 | $3,757 | $209 |
| Diphenoxylate-Atropine | 15 | $1,726 | $115 |
| Omeprazole | 54 | $991 | $18 |
| Azathioprine | 16 | $875 | $55 |
| Peg 3350-Electrolyte | 24 | $471 | $20 |
| Famotidine | 21 | $451 | $21 |
| Pantoprazole | 21 | $433 | $21 |
2021: 12 drugs
| Dexilant | 20 | $17,708 | $885 |
| Suprep | 159 | $17,519 | $110 |
| Budesonide Dr | 17 | $2,674 | $157 |
| Omeprazole | 71 | $1,983 | $28 |
| Cholestyramine | 12 | $1,822 | $152 |
| Esomeprazole Magnesium | 12 | $1,468 | $122 |
| Diphenoxylate-Atropine | 14 | $1,287 | $92 |
| Azathioprine | 15 | $978 | $65 |
| Pantoprazole | 12 | $355 | $30 |
| Famotidine | 20 | $343 | $17 |
| Dicyclomine | 11 | $327 | $30 |
| Peg 3350-Electrolyte | 13 | $192 | $15 |
2020: 12 drugs
| Dexilant | 26 | $21,324 | $820 |
| Creon | 12 | $19,521 | $1,627 |
| Suprep | 128 | $13,411 | $105 |
| Budesonide Ec | 14 | $3,205 | $229 |
| Diphenoxylate-Atropine | 21 | $2,040 | $97 |
| Octreotide Acetate | 11 | $1,531 | $139 |
| Omeprazole | 69 | $1,471 | $21 |
| Azathioprine | 17 | $1,219 | $72 |
| Lansoprazole | 15 | $512 | $34 |
| Pantoprazole | 19 | $499 | $26 |
| Famotidine | 32 | $405 | $13 |
| Peg 3350-Electrolyte | 21 | $338 | $16 |
2019: 16 drugs
| Dexilant | 43 | $25,675 | $597 |
| Suprep | 169 | $16,948 | $100 |
| Creon | 12 | $13,429 | $1,119 |
| Diphenoxylate-Atropine | 20 | $2,139 | $107 |
| Azathioprine | 12 | $1,122 | $93 |
| Omeprazole | 52 | $822 | $16 |
| Lansoprazole | 12 | $442 | $37 |
| Pantoprazole | 15 | $398 | $27 |
| Peg 3350-Electrolyte | 20 | $348 | $17 |
| Propranolol | 14 | $332 | $24 |
| Ranitidine | 13 | $325 | $25 |
| Ondansetron Odt | 17 | $300 | $18 |
| Gavilyte-N | 16 | $261 | $16 |
| Spironolactone | 12 | $259 | $22 |
| Nortriptyline | 12 | $250 | $21 |
| Famotidine | 17 | $127 | $7 |
2018: 11 drugs
| Dexilant | 14 | $10,848 | $775 |
| Suprep | 29 | $2,703 | $93 |
| Azathioprine | 18 | $1,928 | $107 |
| Peg 3350-Electrolyte | 83 | $1,372 | $17 |
| Omeprazole | 62 | $940 | $15 |
| Diphenoxylate-Atropine | 11 | $588 | $53 |
| Gavilyte-N | 37 | $576 | $16 |
| Nortriptyline | 13 | $318 | $24 |
| Polyethylene Glycol 3350 | 11 | $198 | $18 |
| Pantoprazole | 11 | $149 | $14 |
| Famotidine | 16 | $139 | $9 |
2017: 9 drugs
| Dexilant | 22 | $14,893 | $677 |
| Azathioprine | 25 | $2,103 | $84 |
| Omeprazole | 84 | $1,522 | $18 |
| Peg 3350-Electrolyte | 106 | $1,499 | $14 |
| Gavilyte-N | 42 | $713 | $17 |
| Famotidine | 15 | $413 | $28 |
| Ondansetron Odt | 21 | $340 | $16 |
| Pantoprazole | 17 | $280 | $16 |
| Ranitidine | 11 | $153 | $14 |
2016: 12 drugs
| Asacol Hd | 11 | $22,365 | $2,033 |
| Dexilant | 41 | $16,480 | $402 |
| Creon | 11 | $9,551 | $868 |
| Famotidine | 21 | $2,474 | $118 |
| Peg 3350-Electrolyte | 77 | $1,141 | $15 |
| Omeprazole | 65 | $1,046 | $16 |
| Azathioprine | 14 | $1,026 | $73 |
| Diphenoxylate-Atropine | 16 | $1,019 | $64 |
| Ursodiol | 19 | $657 | $35 |
| Gavilyte-N | 32 | $579 | $18 |
| Pantoprazole | 22 | $388 | $18 |
| Polyethylene Glycol 3350 | 11 | $249 | $23 |
2015: 11 drugs
| Dexilant | 37 | $17,363 | $469 |
| Creon | 21 | $12,832 | $611 |
| Carafate | 20 | $7,984 | $399 |
| Peg 3350-Electrolyte | 89 | $1,569 | $18 |
| Omeprazole | 76 | $1,558 | $20 |
| Gavilyte-N | 38 | $708 | $19 |
| Azathioprine | 14 | $491 | $35 |
| Polyethylene Glycol 3350 | 21 | $434 | $21 |
| Pantoprazole | 25 | $385 | $15 |
| Dicyclomine | 24 | $282 | $12 |
| Nortriptyline | 15 | $237 | $16 |
2014: 7 drugs
| Dexilant | 26 | $10,897 | $419 |
| Omeprazole | 84 | $1,957 | $23 |
| Peg-3350 | 59 | $1,094 | $19 |
| Polyethylene Glycol 3350 | 19 | $444 | $23 |
| Azathioprine | 13 | $395 | $30 |
| Gavilyte-N | 18 | $314 | $17 |
| Pantoprazole | 11 | $229 | $21 |
2013: 12 drugs
| Nexium | 15 | $9,950 | $663 |
| Dexilant | 26 | $9,565 | $368 |
| Omeprazole | 75 | $2,484 | $33 |
| Peg-3350 With Flavor Packs | 59 | $1,116 | $19 |
| Moviprep | 11 | $777 | $71 |
| Pantoprazole | 15 | $744 | $50 |
| Diphenoxylate-Atropine | 13 | $683 | $53 |
| Polyethylene Glycol 3350 | 27 | $579 | $21 |
| Azathioprine | 11 | $374 | $34 |
| Gavilyte-N | 17 | $300 | $18 |
| Trilyte With Flavor Packets | 15 | $258 | $17 |
| Nortriptyline | 17 | $233 | $14 |
Money from drug and device companies
$62 in 2025
| 2025 | 2 | 2 | None | $62 |
| 2023 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Velsipity | $31 | 1 payment
|
| Azurity Pharmaceuticals | Sutab | $31 | 1 payment
|
See all 2 published payments
| Azurity Pharmaceuticals | Meals · 2025-11-19 | Sutab | $31 |
| Pfizer | Education · 2025-04-14 | Velsipity | $31 |
See earlier years (2023)
2023: $14
| AbbVie | Linzess | $14 | 1 payment
|
Professional record
- NPI
- 1790796449
- Licence
- CA A75552California A75552: Current · expires 2027-04-30
- Trained
- University of California, San Francisco School of Medicine, 2000
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-08-10
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301